405 related articles for article (PubMed ID: 36059838)
1. Genetic and environmental risk factors for rheumatoid arthritis.
Deane KD; Demoruelle MK; Kelmenson LB; Kuhn KA; Norris JM; Holers VM
Best Pract Res Clin Rheumatol; 2017 Feb; 31(1):3-18. PubMed ID: 29221595
[TBL] [Abstract][Full Text] [Related]
2. When and where does inflammation begin in rheumatoid arthritis?
Demoruelle MK; Deane KD; Holers VM
Curr Opin Rheumatol; 2014 Jan; 26(1):64-71. PubMed ID: 24247116
[TBL] [Abstract][Full Text] [Related]
3. A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis.
He Y; Ge C; Moreno-Giró À; Xu B; Beusch CM; Sandor K; Su J; Cheng L; Lönnblom E; Lundqvist C; Slot LM; Tong D; Urbonaviciute V; Liang B; Li T; Lahore GF; Aoun M; Malmström V; Rispens T; Ernfors P; Svensson CI; Scherer HU; Toes REM; Gjertsson I; Ekwall O; Zubarev RA; Holmdahl R
Nat Commun; 2023 Feb; 14(1):691. PubMed ID: 36754962
[TBL] [Abstract][Full Text] [Related]
4. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.
Zhong Q; Xiao X; Qiu Y; Xu Z; Chen C; Chong B; Zhao X; Hai S; Li S; An Z; Dai L
MedComm (2020); 2023 Jun; 4(3):e261. PubMed ID: 37143582
[TBL] [Abstract][Full Text] [Related]
5. Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis.
Haro I; Sanmartí R; Gómara MJ
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555449
[TBL] [Abstract][Full Text] [Related]
6. Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation.
Cîrciumaru A; Afonso MG; Wähämaa H; Krishnamurthy A; Hansson M; Mathsson-Alm L; Keszei M; Stålesen R; Ottosson L; de Vries C; Shelef MA; Malmström V; Klareskog L; Catrina AI; Grönwall C; Hensvold A; Réthi B
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189377
[TBL] [Abstract][Full Text] [Related]
7. Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis.
Castellar-Mendoza C; Castillo DM; Chila-Moreno L; Bautista-Molano W; Romero-Sánchez C
Clin Oral Investig; 2023 Jul; 27(7):3509-3519. PubMed ID: 37133700
[TBL] [Abstract][Full Text] [Related]
8. Integrative Proteomics and N-Glycoproteomics Analyses of Rheumatoid Arthritis Synovium Reveal Immune-Associated Glycopeptides.
Xu Z; Liu Y; He S; Sun R; Zhu C; Li S; Hai S; Luo Y; Zhao Y; Dai L
Mol Cell Proteomics; 2023 May; 22(5):100540. PubMed ID: 37019382
[TBL] [Abstract][Full Text] [Related]
9. Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review.
Stainer A; Tonutti A; De Santis M; Amati F; Ceribelli A; Bongiovanni G; Torrisi C; Iacopino A; Mangiameli G; Aliberti S; Selmi C
Front Med (Lausanne); 2023; 10():1129939. PubMed ID: 37007765
[TBL] [Abstract][Full Text] [Related]
10. Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development.
Raposo B; Afonso M; Israelsson L; Wähämaa H; Stålesen R; Wermeling F; Hensvold AH; Grönwall C; Rethi B; Klareskog L; Malmström V
Ann Rheum Dis; 2023 May; 82(5):724-726. PubMed ID: 36604150
[No Abstract] [Full Text] [Related]
11. IgG subclass and Fc glycosylation shifts are linked to the transition from pre- to inflammatory autoimmune conditions.
Buhre JS; Becker M; Ehlers M
Front Immunol; 2022; 13():1006939. PubMed ID: 36405742
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.
Zhao T; Wei Y; Zhu Y; Xie Z; Hai Q; Li Z; Qin D
Front Immunol; 2022; 13():1007165. PubMed ID: 36159786
[TBL] [Abstract][Full Text] [Related]
13. Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis.
Aripova N; Duryee MJ; England BR; Hunter CD; Mordeson JE; Ryan EM; Daubach EC; Romberger DJ; Thiele GM; Mikuls TR
Front Immunol; 2023; 14():1203548. PubMed ID: 37654483
[TBL] [Abstract][Full Text] [Related]
14. Effects of bile salt-stimulated lipase on blood cells and associations with disease activity in human inflammatory joint disorders.
Lindquist S; Wang Y; Andersson EL; Tsuji Grebe S; Alenius GM; Rantapää-Dahlqvist S; Lundberg L; Hernell O
PLoS One; 2023; 18(8):e0289980. PubMed ID: 37566600
[TBL] [Abstract][Full Text] [Related]
15. Low-Intensity Physical Exercise Decreases Inflammation and Joint Damage in the Preclinical Phase of a Rheumatoid Arthritis Murine Model.
González-Chávez SA; López-Loeza SM; Acosta-Jiménez S; Cuevas-Martínez R; Pacheco-Silva C; Chaparro-Barrera E; Pacheco-Tena C
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979423
[TBL] [Abstract][Full Text] [Related]
16. Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients.
Meng Y; Zheng X; Zhang Z; Geng H; Li X
Ir J Med Sci; 2023 Dec; 192(6):3187-3194. PubMed ID: 36826711
[TBL] [Abstract][Full Text] [Related]
17. Disease mechanisms in preclinical rheumatoid arthritis: A narrative review.
Romão VC; Fonseca JE
Front Med (Lausanne); 2022; 9():689711. PubMed ID: 36059838
[TBL] [Abstract][Full Text] [Related]
18. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
Bläss S; Engel JM; Burmester GR
Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
[TBL] [Abstract][Full Text] [Related]
19. Potential Pharmacologic Targets for the Prevention of Rheumatoid Arthritis.
Isaacs JD; Iqbal K
Clin Ther; 2019 Jul; 41(7):1312-1322. PubMed ID: 31196649
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
